Lipella pharmaceuticals marks successful first year with strategic progress and key milestones accomplished

Pittsburgh, dec. 20, 2023 (globe newswire) -- lipella pharmaceuticals inc., (nasdaq: lipo) ("lipella," "our," "us" or the "company"), a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. based in pittsburgh, pa, the company has made substantial strides over the past year, achieving critical milestones and advancing its pipeline with three clinical indications and two orphan drug designations granted.
LIPO Ratings Summary
LIPO Quant Ranking